Two Sigma Investments’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Two Sigma Investments's RGEN Position: Q1 2026 in Review
Two Sigma Investments sold out of Repligen (RGEN) in Q1 2026, closing a stake of 8,400 shares — an estimated $1.38M sold.
Two Sigma Investments first reported a position in RGEN in Q2 2013 and held it in 31 quarters. The position peaked at $64.9M in Q3 2024. 443 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Two Sigma Investments reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
- Two Sigma Investments sold 8,400 Repligen shares in Q1 2026, an estimated $1.38M.
- Two Sigma Investments first reported a position in Repligen in Q2 2013 and held it in 31 quarters.
- Two Sigma Investments's Repligen position peaked at $64.9M in Q3 2024.
- 443 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.